No article text was recorded for this version.
metabolic-based therapeutic stratification
Version 1 of 133 papers34 conceptsfrozen 2026-10-04
Papers in this version
- Blog: A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup
- Blog: Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
- Blog: An extensive bioinformatics study on the role of mitochondrial solute carrier family 25 in PC and its mechanism behind affecting immune infiltration and tumor energy metabolism
- Blog: Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer
- Blog: Treatment of metastatic castration-resistant prostate cancer: review of current evidence and synthesis of expert opinions on radioligand therapy
- Blog: A High-Throughput Sequencing Data-Based Classifier Reveals the Metabolic Heterogeneity of Hepatocellular Carcinoma
- Blog: Comprehensive Analysis of Glycolysis-Related Genes for Prognosis, Immune Features, and Candidate Drug Development in Colon Cancer
- Blog: Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
- Blog: The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma
- Blog: Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patients
- Blog: GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
- Blog: Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
- Blog: Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma
- Blog: Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
- Blog: A Metabolism-Related Gene Signature Predicts the Prognosis of Breast Cancer Patients: Combined Analysis of High-Throughput Sequencing and Gene Chip Data Sets
- Blog: Survival patterns after perioperative treatment escalation and cystectomy for synchronous oligometastatic bladder cancer (M1a/M1b) – a population-based series
- Blog: Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
- Blog: Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
- Blog: Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma
- Blog: Gene signatures of copper metabolism related genes may predict prognosis and immunity status in Ewing’s sarcoma
- Blog: Predictors of HbA1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study
- Blog: Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer
- Blog: A novel disulfidptosis-related mRNA signature predicts prognosis and therapeutic response in lung squamous cell carcinoma
- Blog: A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells
- Blog: A Five Glutamine-Associated Signature Predicts Prognosis of Prostate Cancer and Links Glutamine Metabolism with Tumor Microenvironment
- Blog: A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma
- Blog: Comprehensive analyses of fatty acid metabolism-related lncRNA for ovarian cancer patients
- Blog: A lactate related signature for predicting prognosis and tumor microenvironment in lung adenocarcinoma
- Blog: SCO‐ph: Microfluidic Dynamic Phenotyping Platform for High‐Throughput Screening of Single Cell Acidification
- Blog: Personalized treatment decision-making using a machine learning-derived lactylation signature for breast cancer prognosis
- Blog: LAC-TME classifier: machine learning-driven model predicts survival and prioritizes targeted therapy in clear cell renal cell carcinoma
- Blog: Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer
- Blog: Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma
History & citation
Current · Permanent link
- Metabolic Risk Stratification for Personalized Cancer Therapy merged into this direction (62% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_metabolic_based_therapeutic_stratificati_edcbc497,
title = {metabolic-based therapeutic stratification},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/metabolic-based-therapeutic-stratification/rdr_edcbc4978b4543a2b98c0f0efe5a6e0c},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_metabolic_based_therapeutic_stratificati_edcbc497_v1,
title = {metabolic-based therapeutic stratification},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/metabolic-based-therapeutic-stratification/rdr_edcbc4978b4543a2b98c0f0efe5a6e0c/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}